Brief: TG Therapeutics Announces Schedule Of Data Presentations For Briumvi® (Ublituximab) In Multiple Sclerosis At The Americas Committee For Treatment And Research In Multiple Sclerosis Annual Forum
18/02/2025 14:02
Feb 18 (Reuters) - TG Therapeutics Inc TGTX.O :
* TG THERAPEUTICS ANNOUNCES SCHEDULE OF DATA PRESENTATIONS
FOR
BRIUMVI® (UBLITUXIMAB) IN MULTIPLE SCLEROSIS AT THE AMERICAS
COMMITTEE FOR TREATMENT AND RESEARCH IN MULTIPLE SCLEROSIS
ANNUAL FORUM
Source text: ID:nGNX4gKSYN
Further company coverage: TGTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TG Therapeutics
See all newsTG Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Tg Therapeutics Reports Second Quarter 2026 Financial Results And Raises Briumvi® Revenue Guidance
TG Therapeutics Q2 product revenue rises 70% on BRIUMVI sales
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj